<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0129">
 <label>129</label>
 <element-citation publication-type="journal" id="sbref0129">
  <person-group person-group-type="author">
   <name>
    <surname>Gallotta</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Assi</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>É</surname>
    <given-names>Degagné</given-names>
   </name>
   <name>
    <surname>Kannan</surname>
    <given-names>SK</given-names>
   </name>
   <name>
    <surname>Coffman</surname>
    <given-names>RL</given-names>
   </name>
   <name>
    <surname>Guiducci</surname>
    <given-names>C</given-names>
   </name>
  </person-group>
  <article-title>Inhaled TLR9 Agonist renders lung tumors permissive to PD-1 blockade by promoting optimal CD4 and CD8 T-cell interplay</article-title>
  <source>Cancer Res</source>
  <volume>78</volume>
  <year>2018</year>
  <fpage>4943</fpage>
  <lpage>4956</lpage>
  <pub-id pub-id-type="pmid">29945961</pub-id>
 </element-citation>
</ref>
